Open AccessFavipiravir: A Critical Review of Pharmacology, Pre-Clinical Data, and Emerging Clinical Uses in COVID-19
Author(s) -
Anuja S. Motule
Publication year - 2021
Publication title -
international journal for research in applied science and engineering technology
Language(s) - English
Resource type - Journals
ISSN - 2321-9653
DOI - 10.22214/ijraset.2021.37739
Subject(s) - favipiravir , pandemic , covid-19 , context (archaeology) , antiviral drug , medicine , clinical trial , drug , outbreak , virology , pharmacology , intensive care medicine , disease , infectious disease (medical specialty) , biology , paleontology
Since last two years, whole world is going through the pandemic situation of Corona Virus Disease-19 (COVID-19). It caused more than 43 lakhs deaths worldwide. COVID-19 outbreak all over the world has led the researchers and Scientists to develop drugs or vaccines to prevent the spreading of this virus. Due to the unavailabity of proper drug treatment, various veterinary drugs are trying in humans. It is one of such type of antiviral drug which was previously used in treatment of viral infection in animals and birds. In this article, we have tried to provide a comprehensive, evidence-based review of this drug in the context of the present pandemic to elucidate its role in the management of COVID-19. Keywords: Favipiravir; Pharmacology; COVID-19; Antiviral; Clinical trials.